Loading insider details...
Beta
Latest Form 4 (Jul 13, 2026): Disposition to Issuer of 177,523 ESPR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 13, 2026 | Esperion Therapeutics, Inc. (ESPR) | Disposition to Issuer | 177,523 | n/a |
| Jun 1, 2026 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 79,873 | n/a |
| Jun 2, 2025 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 33,000 | n/a |
| Nov 1, 2024 | Catalent, Inc. (CTLT) | Grant/Award | 4,663 | n/a |
| May 24, 2024 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 23,000 | n/a |
| Jun 16, 2023 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 5,150 | n/a |
| May 11, 2023 | Esperion Therapeutics, Inc. (ESPR) | Purchase | 8,409 | $12.5K |
| Jun 3, 2022 | Esperion Therapeutics, Inc. (ESPR) | Purchase | 5,000 | $28.2K |
| Jun 1, 2022 | Esperion Therapeutics, Inc. (ESPR) | Grant/Award | 40,000 | n/a |
| Aug 13, 2021 | TherapeuticsMD, Inc. (TXMD) | Exercise/Conversion | 96,864 | n/a |